WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, K. J.
Right arrow Articles by Hsu, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, K. J.
Right arrow Articles by Hsu, C. Y.

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 15, 2002, 22(22):9764-9770

Amyloid-beta Induces Smac Release via AP-1/Bim Activation in Cerebral Endothelial Cells

K. J. Yin, J.-M. Lee, S. D. Chen, J. Xu, and C. Y. Hsu

Department of Neurology and Center for the Study of Nervous System Injury, Washington University School of Medicine, St. Louis, Missouri 63110


    ABSTRACT

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Insoluble fibrils of amyloid-beta peptide (Abeta ) are the major component of senile and vascular plaques found in the brains of Alzheimer's disease (AD) patients. Abeta has been implicated in neuronal and vascular degeneration because of its toxicity to neurons and endothelial cells in vitro; some of these cells die with characteristic features of apoptosis. We used primary cultures of murine cerebral endothelial cells (CECs) to explore the mechanisms involved in Abeta -induced cell death. We report here that Abeta 25-35, a cytotoxic fragment of Abeta , induced translocation of the apoptosis regulator termed second-mitochondria-derived activator of caspase (Smac) from the intramembranous compartment of the mitochondria to the cytosol 24 hr after exposure. In addition, we demonstrated that X chromosome-linked inhibitor-of-apoptosis protein (XIAP) coimmunoprecipitated with Smac, suggesting that the two proteins bound to one another subsequent to the release of Smac from the mitochondria. Abeta 25-35 treatment also led to rapid AP-1 activation and subsequent expression of Bim, a member of the BH3-only family of proapoptotic proteins. Bim knockdown using an antisense oligonucleotide strategy suppressed Abeta 25-35-induced Smac release and resulted in attenuation of CEC death. Furthermore, AP-1 inhibition, with curcumin or c-fos antisense oligonucleotide, reduced bim expression. These results suggest that Abeta activates an apoptotic cascade involving AP-1 DNA binding, subsequent bim induction, followed by Smac release and binding to XIAP, resulting in CEC death.

Key words: amyloid-beta peptide (Abeta ); Smac; cerebral endothelial cells; AP-1; BH3-only family; XIAP; cell death; Alzheimer's disease


    INTRODUCTION

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Alzheimer's disease (AD), a common neurodegenerative disease that leads to progressive dementia, results from amyloid-beta peptide (Abeta ) deposition in senile plaques and the formation of neurofibrillary tangles (Wisniewski and Wegiel, 1995; Yankner, 1996; Selkoe, 1999). Abeta is a 39-43 amino acid peptide fragment derived from the beta -amyloid precursor protein, a membrane-bound glycoprotein distributed in many cell types of the nervous system (Glenner et al., 1984; Masters et al., 1985). A large body of literature suggests that Abeta accumulation may be involved in the neuronal degenerative process in AD brains (Yankner et al., 1989; Behl et al., 1994; Yankner, 1996; Selkoe, 1999). Abeta , which also accumulates in cerebrovascular walls, has been shown to induce significant damage to endothelial cells (Thomas et al., 1996) and may contribute to the age-dependent degeneration of cerebral vasculature and the development of cerebral amyloid angiopathy (Perlmutter, 1994; Wisniewski et al., 2000), a major cause of hemorrhagic and ischemic stroke in the elderly with or without AD (Walker, 1997). Although Abeta is toxic to cultured cerebral endothelial cells (CECs) (Price et al., 1997; Preston et al., 1998; Xu et al., 2001a), the underlying molecular mechanism is unclear. Several groups have shown that CECs exposed to Abeta demonstrate features of apoptosis, including DNA condensation and fragmentation, and a requirement for protein synthesis (Blanc et al., 1997; Hase et al., 1997; Suo et al., 1997).

Activation of caspases, a widely recognized feature of apoptosis, occurs either via the death receptor-mediated (tumor necrosis factor-alpha /Fas ligand mediated) pathway (Ashkenazi and Dixit, 1999; Bratton et al., 2000) or the mitochondrial pathway (Green and Reed, 1998; Bratton et al., 2000). In the mitochondrial pathway and in some cases of the death receptor-mediated pathway, members of the Bcl-2 family of proteins associate with the mitochondria and trigger the release of a number of mitochondrial intermembranous proteins involved in subsequent apoptotic signaling (Gross et al., 1999; Wang, 2001). One subclass of the Bcl-2 family proteins that contains only one BH3 domain (e.g., Bim, Bid, Bik, Bak, Bad) translocates to the mitochondria from other cellular compartments and interacts with other Bcl-2 members to regulate mitochondrial protein release (Kelekar and Thompson, 1998; Huang and Strasser, 2000). These pro-apoptotic "BH3 domain only" proteins appear to be transcriptionally regulated during apoptosis (Dijkers et al., 2000; Whitfield et al., 2001). Included among the proteins released by mitochondria during apoptosis are cytochrome c and the novel protein termed second-mitochondria-derived activator of caspase (Smac) (Deveraux and Reed, 1999), which binds to a class of anti-apoptotic proteins known as the inhibitors of apoptosis proteins (IAPs), thereby neutralizing IAP activity to promote caspase activation and apoptotic cell death (Du et al., 2000; Verhagen et al., 2000).

We have demonstrated previously that Abeta induces apoptosis in cultured CECs, resulting from mitochondrial dysfunction and the activation of caspase-8 and -3, and that cell death could be attenuated with broad-spectrum caspase inhibitors (Xu et al., 2001a). In this study, we were interested in understanding regulatory events leading to caspase activation, including regulation of Bim expression, Smac release, and IAP binding in cells exposed to Abeta .


    MATERIALS AND METHODS

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO), whereas cell culture supplies were purchased from Invitrogen (Carlsbad, CA) unless specified otherwise.

Mouse CEC primary culture. Mouse CECs were prepared as described previously (Xu et al., 1998). Briefly, fresh mouse brains in ice-cold HBSS with antibiotics were freed of meninges and superficial blood vessels. The gray matter was homogenized and filtered, and the resulting fraction was then digested sequentially with 4 mg/ml collagenase B for 2 hr and 1 mg/ml collagenase/dispase (Roche Molecular Biochemicals, Indianapolis, IN) for 2 hr, followed by centrifugation in a 40% Percoll solution. The second band containing microvessels was collected and washed before plating onto collagen-coated dishes. Mouse CECs migrating from the vessels were pooled to form a proliferating cell culture that was maintained in DMEM supplemented with 10% FBS, 0.5 mg/ml heparin, and 75 µg/ml endothelial cell growth supplements. Mouse CECs of passages 4-15 that were uniformly positive for factor VIII and vimentin (>95% endothelial cell purity) and characteristic bradykinin receptors were grown to 85-95% confluency before use (Xu et al., 1992).

Treatment with Abeta and Bim antisense oligonucleotide. Although Abeta 1-40 and Abeta 1-42 are the major components of Abeta deposits in the AD brain, in most experimental systems the biological effects of the fragment Abeta 25-35 and Abeta 1-40 are comparable (Loo et al., 1993; Behl et al., 1994; Xu et al., 2001a,c). We have shown previously that Abeta 25-35 has approximately the same potency as Abeta 1-40 in inducing cell death in CECs (Xu et al., 2001a) and oligodendrocytes (Xu et al., 2001b). On the basis of these data, only Abeta 25-35 was used in this study. CECs were treated with 25 µM Abeta 25-35 (Sigma, St. Louis, MO) in serum-free growth medium for 1, 2, 4, 8, 24, and 48 hr. In some experiments, mouse CECs were treated with the antisense morpholino oligonucleotide to Bim according to the protocol provided by the manufacturer (Taylor et al., 1996; Summerton et al., 1997; Summerton and Weller, 1997). The oligonucleotides were custom-made by Gene Tools, LLC (Corvallis, OR) with the following sequences: antisense, 5'-TTACATCAGAAGGTTGCTTGGCCAT-3'; and sense, 5'-TACCGGTTCGTTGGAAGACTACATT-3'. Mouse CECs were incubated with a 5 ml solution consisting of 1.4 µM antisense or sense Bim oligonucleotides and 28 µl of 200 µM ethoxylated polyethylenimine for 3 hr and then switched to normal growth medium for at least 24 hr before exposure to Abeta treatment. For c-fos antisense oligonucleotide treatment, separate batches of CECs were pretreated with a 6 ml mixture containing 2 µM c-fos antisense or sense phosphorothioated oligodeoxynucleotide (ODN) and 0.5 µl of 3 mg/ml Superfect (Qiagen, Valencia, CA) for 3 hr before Abeta treatment. The ODNs were custom-made by Invitrogen (Gaithersburg, MD) with the following sequences: sense, 5'-GGTTTGCCCAAACCACGACCATGATG-3'; and antisense, 5'-CATCATGGTCGTGGTTTGGGCAAACC-3' (Liu et al., 1994; Cui et al., 1999; Xu et al., 2001b).

Subfractionization of cellular proteins from CECs. After treatment, CECs were harvested by centrifugation at 200 × g for 10 min at 4°C. The cell pellets were washed twice with ice-cold PBS, followed by centrifugation at 200 × g for 5 min at 4°C, and resuspended with 5 vol of Buffer A [20 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 250 mM sucrose, 0.1 mM PMSF, 1 mM dithiothreitol (DTT), 4 µg/ml pepstatin, 4 µg/ml leupeptin, 5 µg/ml aprotinin, pH 7.9]. After a 10 min incubation on ice, cells were homogenized with a mini-pestle. The lysates were centrifuged at 750 × g for 15 min at 4°C; the supernatant contained mitochondrial and cytosolic proteins, and the pellet contained nuclei. The pellets were resuspended in 45 µl of buffer B (20 mM HEPES, 1.5 mM MgCl2, 20 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, and 1 mg/ml leupeptin and aprotinin, pH 7.9), and 15 µl of buffer C (20 mM HEPES, 1.2 M KCl, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF, 1 mg/ml leupeptin and aprotinin, pH 7.9) was then added and mixed. The samples were placed on ice for 30 min and centrifuged at 12,000 × g. Supernatants containing nuclear protein were transferred and stored at -80°C until analysis by SDS-PAGE. The cytosolic/mitochondrial fractions were centrifuged at 10,000 × g for 15 min at 4°C, and the resulting mitochondrial pellets were resuspended in buffer A and frozen in multiple samples at -80°C. The supernatant of the 10,000 × g spin was further centrifuged at 100,000 × g for 1 hr at 4°C, and the resulting supernatants (S-100) were removed and stored at -80°C for future analysis. The concentrations of proteins described above were measured by the Lowry method.

Western blot analysis. Samples (20-40 µg of protein) were electrophoresed onto a 10-15% SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were blocked in TBST buffer containing 20 mM Tris-HCl, 5% nonfat milk, 150 mM NaCl, and 0.05% Tween 20, pH 7.5, for 1 hr at room temperature. Thereafter the blot was incubated with primary rabbit anti-Bim antibody (1:1000; Calbiochem, La Jolla, CA), rabbit anti-XIAP antibody (1:500; BD Biosciences, San Diego, CA), goat anti-Smac antibody (1:200; Santa Cruz Biotechnology, Santa Cruz, CA), or mouse anti-actin antiserum (1:500; Santa Cruz Biotechnology), respectively, for 1-2 hr at room temperature. The membrane was washed with TBST three times at 10 min intervals, incubated with the second antibody (1:5000; anti-rabbit, anti-mouse, or anti-goat IgG conjugated with alkaline phosphatase; Promega, Madison, WI) at room temperature for 1 hr, and then washed three times each at 10 min intervals with TBST and two times each for 10 min with TBS (TBST without Tween 20). The color reaction was developed by the Blot AP System according to the technical manual provided by Promega.

Immunofluorescence staining. Mouse CECs grown on coverslips were fixed with 4% paraformaldehyde for 30 min and washed three times with 0.1 M PBS, pH 7.4. The cells were then incubated with a primary goat anti-Smac antibody (1:50; Santa Cruz Biotechnology) overnight at 4°C. On the following day, the cells were incubated with fluorescein-conjugated anti-goat IgG (1:100; Vector Labs, Burlingame, CA) for 1 hr. CECs were counterstained with 1 µg/ml propidium iodide (Molecular Probes, Eugene, OR) to visualize nuclear morphology. Slides were washed, wet mounted, and examined with an Olympus fluorescence microscope.

Coimmunoprecipitation. A total of 2 × 107 CECs were pelleted and then lysed in lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris, pH 7.4, 1 mM EDTA, 1 mM EGTA, pH 8.0, 0.2 mM sodium orthovanadate, 0.5% NP-40, 0.2 mM PMSF, 4 µg/ml pepstatin, 4 µg/ml leupeptin, 5 µg/ml aprotinin) on ice for 30 min. Cellular debris was removed by centrifugation at 16,000 × g for 20 min, and the supernatant was incubated with goat anti-Smac antibody (1:200; Santa Cruz Biotechnology) at a concentration of 2 µg/ml at 4°C for 3 hr. Protein G Sepharose 4 Fast Flow (50% beads in lysis buffer; Amersham Biosciences) was added to the antigen-antibody mixture and incubated with gentle agitation for another 1-2 hr. The immunoprecipitate was washed five times with 500 µl of lysis buffer at 4°C, resuspended in SDS loading buffer, separated on an SDS-polyacrylamide gel, transferred to PVDF membrane, and further analyzed by Western blot using rabbit anti-XIAP antibody (1:500; BD Biosciences) as described previously. Affinity-purified normal goat IgG was used as a negative control for immunoprecipitation.

Electrophoretic mobility shift assay. Electrophoretic mobility shift assay (EMSA) to assess AP-1 binding activity has been described in detail elsewhere (An et al., 1993; Xu et al., 2001b). The following AP-1 consensus oligonucleotide was used: 5'-CGCTTGATGAGTCAGCCGGAA-3' (Promega), end-labeled with gamma -32P-ATP by T4 polynucleotide kinase. The binding reaction was performed in a total volume of 20 µl containing binding buffer (10 mM Tris-HCl, 20 mM NaCl, 1 mM DTT, 1 mM EDTA, 5% glycerol, pH 7.6), 0.0175 pmol of labeled probe (>10,000 cpm), 10-20 µg of nuclear protein, and 1 µg of poly(dI-dC). After incubation for 20 min at room temperature, the mixture was subjected to electrophoresis on a nondenaturing 6% polyacrylamide gel at 180 V for 2 hr under low ionic strength conditions. The gel was dried and subjected to autoradiography. For supershift assays, samples were incubated with anti-c-Jun or anti-c-Fos antibody (1:4; Santa Cruz Biotechnology) for 1 hr before addition of gamma -32P-ATP AP-1 oligonucleotide probe. The specificity of AP-1 DNA binding activity was also demonstrated by the complete inhibition of AP-1 binding in the presence of a 100-fold molar excess of cold AP-1 oligonucleotide (data not shown).

Assessment of mouse CEC death. The extent of CEC death was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) and LDH assays as described previously (Xu et al., 1998, 2000).

Statistical analysis. Quantitative data are expressed as mean ± SD based on at least three separate experiments of triplicate samples. Difference among groups was statistically analyzed by one-way ANOVA followed by Bonferroni's post hoc test. Comparison between two experimental groups was based on a two-tailed t test. A p value <0.05 was considered significant.


    RESULTS

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Smac release from mitochondria and binding to XIAP in CECs

Smac release from mitochondria appears to be a general feature of apoptosis involving the mitochondrial pathway of cell death (Du et al., 2000; Adrain et al., 2001; Carson et al., 2002; Deng et al., 2002; Madesh et al., 2002; Verhagen and Vaux, 2002). We have shown previously that Abeta 25-35 is toxic to CECs, inducing several events in the apoptotic cascade, including cytochrome c release from mitochondria, and subsequent caspase activation (Xu et al., 2001a). To explore whether Smac redistribution from mitochondria to the cytosol in CECs occurs during Abeta 25-35-induced apoptosis, we used Western blotting to analyze the content of Smac in different cellular fractions. As shown in Figure 1A, Smac protein levels increased in the cytosol, at a time when the protein decreased in the mitochondrial fraction (24-48 hr after Abeta 25-35 treatment); the nuclear fraction remained devoid of Smac during this period of time, suggesting that Smac translocated from mitochondria to cytosol. The cellular redistribution of Smac was confirmed by immunofluorescent staining with anti-Smac antibody, which showed that the normal punctate mitochondrial pattern was changed to a more diffuse cytosolic pattern after Abeta 25-35 treatment (Fig. 1B). An immunoprecipitation study with anti-Smac antibody revealed that released Smac bound primarily to XIAP, a member of the IAP family of apoptosis regulators, in the cytosol (Fig. 1C).



View larger version (27K):
[in this window]
[in a new window]
  		Figure 1.   Abeta 25-35-induced mitochondrial Smac release into the cytosol and Smac binding to XIAP. A, Western blot analysis shows the time course of Smac translocation from the mitochondrial (Mt.) to the cytosolic (Cyt.) fraction after Abeta 25-35 exposure for 24 hr. Note the absence of Smac in the nuclear fraction (Nuc.) at all times. Actin immunoblotting serves as a control. B, Immunofluorescent staining with anti-Smac antibody confirms the translocation of Smac from mitochondria (punctate staining) to cytosol (diffuse staining) after Abeta 25-35 exposure for 0 or 24 hr. C, Smac binding to XIAP is demonstrated by coimmunoprecipitation (IP) with anti-Smac but not control (Ctl; normal goat IgG) antibody. Representative data from three separate experiments with similar results are shown.

Regulation of Smac release

Oxidative stress plays a critical role in mediating Abeta -induced apoptotic cell death in multiple cell types (Harris et al., 1995a,b; Davis, 1996; Thomas et al., 1996; Misonou et al., 2000; Xu et al., 2000), and anti-oxidants can protect cells from Abeta toxicity (Xu et al., 2001a). To determine whether inhibition of oxidative stress contributes to improvement of cell survival by inhibiting Smac release, we examined the effects of the antioxidant N-acetyl-cysteine (NAC) on Smac release induced by Abeta 25-35. As illustrated in Figure 2A, NAC effectively inhibited Smac release from mitochondria.



View larger version (48K):
[in this window]
[in a new window]
  		Figure 2.   Regulation of Abeta 25-35-induced Smac release from mitochondria in CECs. CECs were treated with 25 µM Abeta 25-35 in the presence of NAC (A), cyclosporin A (B), or wortmannin (C) at indicated concentrations, and cytosolic fractions were analyzed by immunoblotting with anti-Smac antibody. NAC and cyclosporin A inhibited, whereas wortmannin increased, Smac release. Representative data from three separate experiments with similar results are shown.

It has been proposed that the formation of the mitochondrial permeability transition pore (PTP) may play a role in the release of mitochondrial caspase activators during apoptosis (Pritchard et al., 2000; Buckman and Reynolds, 2001). Cyclosporin A (CsA), which inhibits PTP formation, was used to examine its effect on Abeta 25-35-induced Smac release. CsA significantly prevented Smac release from mitochondria to cytosol (Fig. 2B).

Multiple signal pathways may modulate mitochondrial intermembrane protein release (Imaizumi et al., 1999; Kaltschmidt et al., 1999; Bozyczko-Coyne et al., 2001; Martin et al., 2001; Xu et al., 2001b). To determine whether the phosphotidylinositol 3-kinase (PI3K)/Akt pathway regulates Smac release in CECs, we treated CECs with a PI3K/Akt inhibitor, wortmannin. As shown in Figure 2C, wortmannin increased Smac release.

AP-1 binding activity

Proto-oncogenes belonging to the c-fos and c-jun families are immediate-early genes that are rapidly and transiently induced in response to various stimuli (Kruijer et al., 1984; Kornhauser et al., 1992). These gene products can interact via a leucine zipper to form heterodimers that act as a transcription factor by binding specifically to the AP-1 binding sites in the promotor region of selected genes (Curran and Franza, 1988; Beato, 1991), transactivating downstream genes that constitute the delayed genetic response. In this study, AP-1 binding activity was determined by EMSA. As illustrated in Figure 3A, treatment with Abeta 25-35 resulted in a substantial increase in AP-1 binding activity in a time-dependent manner, starting as early as 1 hr and persisting up to 24 hr after Abeta exposure; low basal levels of AP-1 binding activity were detected in control CECs. Addition of excess of unlabeled AP-1 oligonucleotides abolished the observed DNA-protein complex, demonstrating the specificity of AP-1 DNA binding activity (data not shown). Preincubation of the nuclear extract with anti-c-Jun antibody or anti-c-Fos antibody also reduced AP-1 DNA binding activity (Fig. 3B).



View larger version (52K):
[in this window]
[in a new window]
  		Figure 3.   Abeta 25-35 activation of AP-1. A, EMSA study demonstrates a time-dependent elevation of AP-1 binding activity after Abeta 25-35 treatment in CECs. Note the low level of AP-1 binding in cultures unexposed to Abeta 25-35 (0h). B, The specificity of AP-1 binding is confirmed by the effects of anti-c-Jun or anti-c-Fos antibodies in reducing AP-1 binding activity. Representative data from three separate experiments with similar results are shown. h, Hour.

Bim expression is required for Smac release

Bim belongs to the BH3-only subclass of the Bcl-2 family of apoptosis regulators. These proteins contain only one of the Bcl-2 homology regions (BH3) and are essential initiators of apoptotic cell death (Kelekar and Thompson, 1998; Huang and Strasser, 2000). To determine the possible role of Bim in Abeta -induced cell death, Bim expression was examined in CECs. Western blot analysis showed that Bim expression was increased after Abeta exposure, persisting for up to 24 hr after exposure (Fig. 4A,B).



View larger version (42K):
[in this window]
[in a new window]
  		Figure 4.   Abeta 25-35 induction of Bim protein expression in CECs. A, A representative Western blot demonstrates that Abeta 25-35 induced Bim protein expression at the indicated time points. B, Quantitative analysis of three Western blots (normalized to actin expression) using the NIH image system graphically illustrates Bim protein induction by Abeta 25-35. Data in B are expressed as mean ± SD. **p < 0.05 versus 0 hr (0h) exposure.

Previous studies have reported that the translocation of mitochondrial intermembranous proteins may be under the control of some BH3-only family members (Gross et al., 1999; Li et al., 2001; Wang, 2001; Madesh et al., 2002). To explore the possibility that mitochondrial Smac release was regulated by Bim activation in Abeta -induced cell death, we treated CECs with bim antisense oligonucleotides. Treatment with antisense oligonucleotide diminished the Abeta 25-35-induced increase in bim expression (Fig. 5A). Furthermore, Bim knockdown reduced Smac release from mitochondria (Fig. 5B) and decreased cell death 24 hr after Abeta 25-35 exposure (Fig. 5C,D). To confirm the specificity of bim antisense oligonucleotide, the bim sense oligonucleotide was also tested and had no effect on Bim activation, Smac release, or subsequent cell death (Fig. 5A-D).



View larger version (36K):
[in this window]
[in a new window]
  		Figure 5.   Effects of Bim suppression on Smac release and CEC death. CECs were cultured in the presence or absence of bim sense or antisense oligonucleotide with or without Abeta 25-35 treatment for 24 hr. A, A representative immunoblot demonstrates that bim antisense oligonucleotide reduced bim expression in CECs after Abeta 25-35 exposure. Sense oligonucleotide treatment had no effect. B, bim antisense oligonucleotide reduced mitochondrial Smac release in CECs after Abeta 25-35 treatment, as demonstrated in this representative Western blot, and increased CEC survival, assessed by MTT assay (C) and LDH release (D). Data are expressed as mean ± SD from three separate experiments in quadruplicate. Control, Control without oligonucleotide treatment; AS, antisense oligonucleotide; S, sense oligonucleotide. **p < 0.05 versus control group.

AP-1 inhibition decreases Bim expression

To determine whether AP-1 activity directly regulates bim expression, curcumin, an AP-1 inhibitor, was applied to CECs. As illustrated in Figure 6, treatment with curcumin effectively inhibited AP-1 DNA binding activity (Fig. 6A), resulting in decreased Bim protein levels after 4 hr of exposure to Abeta 25-35 (Fig. 6B). No effects of curcumin on AP-1 activation and bim induction were observed at 2 mM curcumin (Fig. 6A,B). To confirm the effect of AP-1 DNA binding inhibition on bim expression, CECs were treated with c-fos antisense oligonucleotides. This strategy inhibited AP-1 DNA binding (Fig. 6C) by disrupting c-Fos-c-Jun dimerization (Liu et al., 1994; Cui et al., 1999; Xu et al., 2001b) and resulted in decreased Bim expression (Fig. 6D).



View larger version (47K):
[in this window]
[in a new window]
  		Figure 6.   The effect of AP-1 inhibition on Abeta 25-35-induced Bim expression. Curcumin (A) or c-fos antisense (AS) oligonucleotide (C) reduced AP-1 binding activity as shown by EMSA. Curcumin (B) or c-fos antisense oligonucleotide (D) also reduced Bim expression as shown by immunoblotting. C-fos sense (S) oligonucleotide had no effect. Representative data from three separate experiments with similar results are shown.


    DISCUSSION

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The results demonstrate that CECs undergo apoptosis when exposed to Abeta 25-35. This event is accompanied by the translocation of Smac from the mitochondrial intermembranous compartment to the cytosol, where it appears to bind to XIAP. Furthermore, we have provided evidence that Smac release is regulated by expression of the BH3-only protein, Bim. Suppression of Bim expression using a Bim antisense oligonucleotide effectively inhibited Abeta -induced mitochondrial Smac release and reduced subsequent cell death. Bim expression, in turn, is regulated by AP-1 binding activity, because inhibition of AP-1 with curcumin or c-fos antisense oligonucleotide reduced Bim expression. On the basis of these results, we propose that Abeta 25-35 activates AP-1, which transactivates Bim expression. Bim expression then leads to Smac release from mitochondria and subsequent binding to anti-apoptotic XIAP, resulting in CEC apoptosis. This proposed sequence of events is consistent with previous work which demonstrated that Abeta induced CECs to die with features of apoptosis, including DNA condensation and fragmentation (Xu et al., 2001a), and involved mitochondrial dysfunction, mitochondrial DNA damage, and activation of caspase-8 and -3 (Xu et al., 2001a).

Caspase activity has been shown recently to be under the influence of the IAP class of proteins, consisting of NAIP, cIAP-1, cIAP-2, XIAP, and Survivin, which directly bind to and inactivate caspases (Deveraux et al., 1997, 1998; Roy et al., 1997; Shin et al., 2001; Verhagen et al., 2001). The IAPs are regulated by Smac. Several studies have demonstrated that Smac is released from the mitochondria by apoptotic stimuli and then binds to and inactivates the IAPs, disinhibiting caspase activation (Du et al., 2000; Verhagen et al., 2000). In this study we have shown that Smac, in fact, does bind to XIAP. It is likely that Smac binding of XIAP promotes the activation of downstream effector caspases, as observed in our earlier work (Xu et al., 2001a). Because XIAP exists exclusively in the cytosol (Du et al., 2000; Verhagen et al., 2000), interaction with Smac is likely to occur only after its release from the mitochondria.

There is growing evidence that a critical checkpoint in the regulation of apoptosis occurs at the level of the mitochondria and that mitochondrial disruption may lead to the stimulation of apoptosis (Green and Reed, 1998). We examined several interventions that altered mitochondrial susceptibility to damage to determine their effect on Smac release. In general, those interventions that have demonstrated cytoprotective properties reduced Smac release in CECs. For example, the antioxidant NAC, which was reported previously to protect CECs from Abeta 25-35-induced CEC death (Xu et al., 2001a), blocked Smac release in the present study. Likewise, the permeability transition pore inhibitor cyclosporin A reduced Smac release from CECs treated with Abeta 25-35.

Smac release after apoptotic stimuli is controlled by the interaction of Bcl-2 family members on the mitochondrial membrane. For example, several groups have shown that Bcl-2 overexpression inhibited Smac release and attenuated death in cells stimulated by death ligands or via the mitochondrial pathway (Adrain et al., 2001; Fulda et al., 2002; Sun et al., 2002). The involvement of Bax has also been implicated, at least in receptor-mediated apoptosis, because Bax knock-out prevented Smac release and subsequent cell death in TRAIL-induced human colon cancer cells (Deng et al., 2002). In addition, there is growing evidence that receptor-mediated Smac release may require the activation of caspase-8, which cleaves the cytosolic BH3-only protein, Bid, into a truncated form (tBid); tBid then translocates to the mitochondria where it triggers the release of Smac and other apoptotic signals (Li et al., 1998; Luo et al., 1998; Madesh et al., 2002). Another BH3-only protein, Bim, normally associates with cellular microtubule complexes but translocates to the mitochondria shortly after apoptotic stimuli (Putcha et al., 2001). Li et al. (2001) has reported that recombinant Bim alone is as efficient as tBid in releasing cytochrome c and endonuclease G when incubated with mitochondria in vitro. Mice lacking Bim show defects in apoptotic response in their immune system (Bouillet et al., 1999). Because the requirement for mitochondrial processing to activate Smac may be analogous to the requirement for mitochondrial processing of cytochrome c, we explored the relationship between Bim expression and Smac release in Abeta -treated CECs. The results shown here demonstrate that Bim knockdown using an antisense strategy effectively inhibited the release of Smac from mitochondria and reduced CEC cell death, implying that Bim expression regulates Smac release and subsequent cascade activation in Abeta 25-35-induced apoptosis.

Recent reports suggest that the expression of BH3-only proteins such as Bim may primarily involve transcriptional regulation. For example, the forkhead transcription factor induced Bim expression in T lymphocytes and is thought to be suppressed by survival-promoting cytokines via the PI3K/Akt anti-apoptotic pathway (Dijkers et al., 2000). Our finding that the PI3K/Akt inhibitor, wortmannin, increased Smac release in Abeta 25-35-treated CECs raises the possibility that this anti-apoptotic pathway may regulate Bim expression, which in turn influences Smac release. Dominant-negative constructs of c-jun prevented bim upregulation and inhibited mitochondrial cytochrome c release in cultured neurons after NGF withdrawal, suggesting that activation of the JNK/c-Jun pathway may also participate in the transcriptional regulation of bim (Whitfield et al., 2001). In this study, we demonstrated that Abeta 25-35 exposure caused a significant elevation of AP-1 binding activity. AP-1, composed of a heterodimer of c-Fos and c-Jun, is likely to be involved as shown by EMSA. Abeta 25-35 activation of AP-1 is likely to lead to the transactivation of bim. This contention is supported by the finding that inhibition of AP-1 by curcumin or a c-fos antisense oligonucleotide resulted in bim downregulation. In conclusion, the present study suggests a central role for Bim-mediated mitochondrial Smac release in Abeta 25-35-induced CEC apoptosis. This cascade is regulated by upstream c-Jun-c-Fos/AP-1 activity. The elucidation of mechanisms involved in Abeta -induced CEC death may be important for understanding the pathogenesis of cerebral amyloid angiopathy and cell death in Alzheimer's disease.


    FOOTNOTES

Received July 17, 2002; revised Aug. 28, 2002; accepted Sept. 9, 2002.

This work was supported by National Institutes of Health Grants NS37230, NS40162, and NS40525 (C.Y.H.), American Heart Association (AHA) Grant 0050597N (J.X.), and AHA Postdoctoral Fellowship 0120652Z (K.J.Y.).

Correspondence should be addressed to Dr. Chung Y. Hsu, Department of Neurology, Box 8111, Washington University School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110. E-mail: hsuc{at}neuro.wustl.edu.


    REFERENCES

TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Adrain C, Creagh EM, Martin SJ (2001) Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J 20:6627-6636[Web of Science][Medline].
  • An G, Lin TN, Liu JS, Xue JJ, He YY, Hsu CY (1993) Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann Neurol 33:457-464[Web of Science][Medline].
  • Ashkenazi A, Dixit VM (1999) Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11:255-260[Web of Science][Medline].
  • Beato M (1991) Transcriptional control by nuclear receptors. FASEB J 5:2044-2051[Abstract].
  • Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827[Web of Science][Medline].
  • Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP (1997) Amyloid beta-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 68:1870-1881[Web of Science][Medline].
  • Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738[Abstract/Free Full Text].
  • Bozyczko-Coyne D, O'Kane TM, Wu ZL, Dobrzanski P, Murthy S, Vaught JL, Scott RW (2001) CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis. J Neurochem 77:849-863[Web of Science][Medline].
  • Bratton SB, MacFarlane M, Cain K, Cohen GM (2000) Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp Cell Res 256:27-33[Web of Science][Medline].
  • Buckman JF, Reynolds IJ (2001) Spontaneous changes in mitochondrial membrane potential in cultured neurons. J Neurosci 21:5054-5065[Abstract/Free Full Text].
  • Carson JP, Behnam M, Sutton JN, Du C, Wang X, Hunt DF, Weber MJ, Kulik G (2002) Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells. Cancer Res 62:18-23[Abstract/Free Full Text].
  • Cui JK, Hsu CY, Liu PK (1999) Suppression of post-ischemic hippocampal nerve growth factor expression by a c-fos antisense oligodeoxynucleotide. J Neurosci 19:1335-1344[Abstract/Free Full Text].
  • Curran T, Franza Jr BR (1988) Fos and Jun: the AP-1 connection. Cell 55:395-397[Web of Science][Medline].
  • Davis JB (1996) Oxidative mechanisms in beta-amyloid cytotoxicity. Neurodegeneration 5:441-444[Web of Science][Medline].
  • Deng Y, Lin Y, Wu X (2002) TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16:33-45[Abstract/Free Full Text].
  • Deveraux QL, Reed JC (1999) IAP family proteins---suppressors of apoptosis. Genes Dev 13:239-252[Free Full Text].
  • Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300-304[Medline].
  • Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215-2223[Web of Science][Medline].
  • Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ (2000) Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10:1201-1204[Web of Science][Medline].
  • Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42[Web of Science][Medline].
  • Fulda S, Meyer E, Debatin KM (2002) Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21:2283-2294[Web of Science][Medline].
  • Glenner GG, Wong CW, Quaranta V, Eanes ED (1984) The amyloid deposits in Alzheimer's disease: their nature and pathogenesis. Appl Pathol 2:357-369[Medline].
  • Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309-1312[Abstract/Free Full Text].
  • Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument-Bromage H, Tempst P, Korsmeyer SJ (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274:1156-1163[Abstract/Free Full Text].
  • Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM (1995a) Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol 131:193-202[Web of Science][Medline].
  • Harris ME, Carney JM, Cole PS, Hensley K, Howard BJ, Martin L, Bummer P, Wang Y, Pedigo Jr NW, Butterfield DA (1995b) beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. NeuroReport 6:1875-1879[Web of Science][Medline].
  • Hase M, Araki S, Hayashi H (1997) Fragments of amyloid beta induce apoptosis in vascular endothelial cells. Endothelium 5:221-229[Medline].
  • Huang DC, Strasser A (2000) BH3-only proteins---essential initiators of apoptotic cell death. Cell 103:839-842[Web of Science][Medline].
  • Imaizumi K, Morihara T, Mori Y, Katayama T, Tsuda M, Furuyama T, Wanaka A, Takeda M, Tohyama M (1999) The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J Biol Chem 274:7975-7981[Abstract/Free Full Text].
  • Kaltschmidt B, Uherek M, Wellmann H, Volk B, Kaltschmidt C (1999) Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc Natl Acad Sci USA 96:9409-9414[Abstract/Free Full Text].
  • Kelekar A, Thompson CB (1998) Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol 8:324-330[Web of Science][Medline].
  • Kornhauser JM, Nelson DE, Mayo KE, Takahashi JS (1992) Regulation of jun-B messenger RNA and AP-1 activity by light and a circadian clock. Science 255:1581-1584[Abstract/Free Full Text].
  • Kruijer W, Cooper JA, Hunter T, Verma IM (1984) Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312:711-716[Medline].
  • Li H, Zhu H, Xu CJ, Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501[Web of Science][Medline].
  • Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412:95-99[Medline].
  • Liu PK, Salminen A, He YY, Jiang MH, Xue JJ, Liu JS, Hsu CY (1994) Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA. Ann Neurol 36:566-576[Web of Science][Medline].
  • Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955[Abstract/Free Full Text].
  • Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490[Web of Science][Medline].
  • Madesh M, Antonsson B, Srinivasula SM, Alnemri ES, Hajnoczky G (2002) Rapid kinetics of tBid-induced cytochrome c and Smac/DIABLO release and mitochondrial depolarization. J Biol Chem 277:5651-5659[Abstract/Free Full Text].
  • Martin D, Salinas M, Lopez-Valdaliso R, Serrano E, Recuero M, Cuadrado A (2001) Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem 78:1000-1008[Web of Science][Medline].
  • Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757-2763[Web of Science][Medline].
  • Misonou H, Morishima-Kawashima M, Ihara Y (2000) Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39:6951-6959[Medline].
  • Perlmutter LS (1994) Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol Neurobiol 9:33-40[Medline].
  • Preston JE, Hipkiss AR, Himsworth DT, Romero IA, Abbott JN (1998) Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine. Neurosci Lett 242:105-108[Medline].
  • Price JM, Sutton ET, Hellermann A, Thomas T (1997) beta-Amyloid induces cerebrovascular endothelial dysfunction in the rat brain. Neurol Res 19:534-538[Web of Science][Medline].
  • Pritchard DE, Singh J, Carlisle DL, Patierno SR (2000) Cyclosporin A inhibits chromium(VI)-induced apoptosis and mitochondrial cytochrome c release and restores clonogenic survival in CHO cells. Carcinogenesis 21:2027-2033[Abstract/Free Full Text].
  • Putcha GV, Moulder KL, Golden JP, Bouillet P, Adams JA, Strasser A, Johnson EM (2001) Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis. Neuron 29:615-628[Web of Science][Medline].
  • Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC (1997) The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 16:6914-6925[Web of Science][Medline].
  • Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23-31[Medline].
  • Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117-1123[Medline].
  • Summerton J, Weller D (1997) Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev 7:187-195[Web of Science][Medline].
  • Summerton J, Stein D, Huang SB, Matthews P, Weller D, Partridge M (1997) Morpholino and phosphorothioate antisense oligomers compared in cell-free and in-cell systems. Antisense Nucleic Acid Drug Dev 7:63-70[Web of Science][Medline].
  • Sun XM, Bratton SB, Butterworth M, MacFarlane M, Cohen GM (2002) Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein. J Biol Chem 277:11345-11351[Abstract/Free Full Text].
  • Suo Z, Fang C, Crawford F, Mullan M (1997) Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity. Brain Res 762:144-152[Web of Science][Medline].
  • Taylor MF, Paulauskis JD, Weller DD, Kobzik L (1996) In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-alpha mRNA. J Biol Chem 271:17445-17452[Abstract/Free Full Text].
  • Thomas T, Thomas G, McLendon C, Sutton T, Mullan M (1996) beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380:168-171[Medline].
  • Verhagen AM, Vaux DL (2002) Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 7:163-166[Web of Science][Medline].
  • Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43-53[Web of Science][Medline].
  • Verhagen AM, Coulson EJ, Vaux DL (2001) Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs. Genome Biol 2:3009.1-3009.10.
  • Walker LC (1997) Animal models of cerebral beta-amyloid angiopathy. Brain Res Brain Res Rev 25:70-84[Medline].
  • Wang X (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15:2922-2933[Free Full Text].
  • Whitfield J, Neame SJ, Paquet L, Bernard O, Ham J (2001) Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 29:629-643[Web of Science][Medline].
  • Wisniewski HM, Wegiel J (1995) The neuropathology of Alzheimer's disease. Neuroimaging Clin N Am 5:45-57[Medline].
  • Wisniewski HM, Wegiel J, Vorbrodt AW, Mazur-Kolecka B, Frackowiak J (2000) Role of perivascular cells and myocytes in vascular amyloidosis. Ann NY Acad Sci 903:6-18[Web of Science][Medline].
  • Xu J, Qu ZX, Moore SA, Hsu CY, Hogan EL (1992) Receptor-linked hydrolysis of phosphoinositides and production of prostacyclin in cerebral endothelial cells. J Neurochem 58:1930-1935[Web of Science][Medline].
  • Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, Choi DW, Hsu CY (1998) Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 273:16521-16526[Abstract/Free Full Text].
  • Xu J, He L, Ahmed SH, Chen SW, Goldberg MP, Beckman JS, Hsu CY (2000) Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 31:1744-1751[Abstract/Free Full Text].
  • Xu J, Chen S, Ku G, Ahmed SH, Chen H, Hsu CY (2001a) Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation. J Cereb Blood Flow Metab 21:702-710[Web of Science][Medline].
  • Xu J, Chen S, Ahmed SH, Chen H, Ku G, Goldberg MP, Hsu CY (2001b) Amyloid-beta peptides are cytotoxic to oligodendrocytes. J Neurosci 21:RC118[Abstract/Free Full Text](1-5).
  • Xu J, Kim GM, Ahmed SH, Yan P, Xu XM, Hsu CY (2001c) Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 21:92-97[Abstract/Free Full Text].
  • Yankner BA (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16:921-932[Web of Science][Medline].
  • Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245:417-420[Abstract/Free Full Text].

Copyright © 2002 Society for Neuroscience  0270-6474/02/22229764-07$05.00/0


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Guo, W. J. Kim, J. Lok, S.-R. Lee, E. Besancon, B.-H. Luo, M. F. Stins, X. Wang, S. Dedhar, and E. H. Lo
Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
PNAS, May 27, 2008; 105(21): 7582 - 7587.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Ma, C. Ying, Z. Yuan, B. Song, D. Li, Y. Liu, B. Lai, W. Li, R. Chen, Y.-P. Ching, et al.
dp5/HRK Is a c-Jun Target Gene and Required for Apoptosis Induced by Potassium Deprivation in Cerebellar Granule Neurons
J. Biol. Chem., October 19, 2007; 282(42): 30901 - 30909.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M.-J. Hsu, C. Y. Hsu, B.-C. Chen, M.-C. Chen, G. Ou, and C.-H. Lin
Apoptosis Signal-Regulating Kinase 1 in Amyloid {beta} Peptide-Induced Cerebral Endothelial Cell Apoptosis
J. Neurosci., May 23, 2007; 27(21): 5719 - 5729.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Yao, T.-V. V. Nguyen, and C. J. Pike
Estrogen Regulates Bcl-w and Bim Expression: Role in Protection against {beta}-Amyloid Peptide-Induced Neuronal Death
J. Neurosci., February 7, 2007; 27(6): 1422 - 1433.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. C. Biswas, Y. Shi, J.-P. G. Vonsattel, C. L. Leung, C. M. Troy, and L. A. Greene
Bim Is Elevated in Alzheimer's Disease Neurons and Is Required for {beta}-Amyloid-Induced Neuronal Apoptosis
J. Neurosci., January 24, 2007; 27(4): 893 - 900.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K.-J. Yin, J. R. Cirrito, P. Yan, X. Hu, Q. Xiao, X. Pan, R. Bateman, H. Song, F.-F. Hsu, J. Turk, et al.
Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-beta Peptide Catabolism
J. Neurosci., October 25, 2006; 26(43): 10939 - 10948.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
D. L. Dickstein, K. E. Biron, M. Ujiie, C. G. Pfeifer, A. R. Jeffries, and W. A. Jefferies
A{beta} peptide immunization restores blood-brain barrier integrity in Alzheimer disease
FASEB J, March 1, 2006; 20(3): 426 - 433.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K.-J. Yin, C. Y. Hsu, X.-Y. Hu, H. Chen, S.-W. Chen, J. Xu, and J.-M. Lee
Protein phosphatase 2A regulates bim expression via the Akt/FKHRL1 signaling pathway in amyloid-beta peptide-induced cerebrovascular endothelial cell death.
J. Neurosci., February 22, 2006; 26(8): 2290 - 2299.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Luciano, D. Zhai, X. Zhu, B. Bailly-Maitre, J.-E. Ricci, A. C. Satterthwait, and J. C. Reed
Cytoprotective Peptide Humanin Binds and Inhibits Proapoptotic Bcl-2/Bax Family Protein BimEL
J. Biol. Chem., April 22, 2005; 280(16): 15825 - 15835.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Yao, T.-V. V. Nguyen, and C. J. Pike
{beta}-Amyloid-Induced Neuronal Apoptosis Involves c-Jun N-Terminal Kinase-Dependent Downregulation of Bcl-w
J. Neurosci., February 2, 2005; 25(5): 1149 - 1158.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
J. Hess, P. Angel, and M. Schorpp-Kistner
AP-1 subunits: quarrel and harmony among siblings
J. Cell Sci., December 1, 2004; 117(25): 5965 - 5973.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. Marques, U. Keil, A. Bonert, B. Steiner, C. Haass, W. E. Muller, and A. Eckert
Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation: OXIDATIVE STRESS, CASPASES, AND THE JNK PATHWAY
J. Biol. Chem., July 18, 2003; 278(30): 28294 - 28302.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
C. Iadecola and P. B. Gorelick
Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia
Stroke, February 1, 2003; 34(2): 335 - 337.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yin, K. J.
Right arrow Articles by Hsu, C. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, K. J.
Right arrow Articles by Hsu, C. Y.

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-